| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 18.22▼ | 18.22▼ | 18.18▼ | 18.32▼ | 18.28▼ |
| MA10 | 18.19▼ | 18.19▼ | 18.28▼ | 18.37▼ | 18.41▼ |
| MA20 | 18.31▼ | 18.31▼ | 18.30▼ | 18.28▼ | 18.04▲ |
| MA50 | 17.81▲ | 17.53▲ | 17.37▲ | 18.42▼ | 17.04▲ |
| MA100 | 16.95▲ | 16.79▲ | 16.77▲ | 18.02▲ | 16.97▲ |
| MA200 | 17.00▲ | 16.90▲ | 16.89▲ | 17.16▲ | 17.63▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.058▼ | -0.074▼ | -0.077▼ | -0.017▼ | -0.046▼ |
| RSI | 51.066▲ | 52.219▲ | 52.286▲ | 40.487▼ | 54.001▲ |
| STOCH | 43.524 | 43.524 | 36.876 | 48.488 | 42.296 |
| WILL %R | -65.254 | -65.254 | -75.000▼ | -90.660▼ | -52.988 |
| CCI | -50.539 | -50.539 | -78.097 | -138.756▼ | -2.811 |
|
Friday, October 31, 2025 10:25 AM
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 3% year on year to $7.77 billion. On the other hand, the ...
|
|
Thursday, October 30, 2025 01:54 PM
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) announced better-than-expected revenue in Q3 CY2025, with sales up 3% year on year to $7.77 billion. On the other hand, the company’s full-year ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/10/25 | 18.08 | 18.1239 | 18.08 | 18.1239 | 2,187 |
| 30/10/25 | 18.20 | 18.20 | 18.1398 | 18.1398 | 198 |
| 29/10/25 | 18.35 | 18.3715 | 18.2554 | 18.2554 | 2,009 |
| 28/10/25 | 18.45 | 18.55 | 18.45 | 18.541 | 703 |
| 27/10/25 | 18.495 | 18.55 | 18.495 | 18.5396 | 577 |
| 24/10/25 | 18.55 | 18.55 | 18.5085 | 18.5085 | 258 |
| 23/10/25 | 18.50 | 18.5128 | 18.50 | 18.5128 | 211 |
| 22/10/25 | 18.445 | 18.4503 | 18.445 | 18.4503 | 256 |
| 21/10/25 | 18.29 | 18.3699 | 18.29 | 18.3316 | 717 |
| 20/10/25 | 18.3441 | 18.3441 | 18.3441 | 18.3441 | 103 |
|
|
||||
|
|
||||
|
|